Development and Validation of Risk Prediction Models for Coronary Heart Disease and Heart Failure After Treatment for Hodgkin Lymphoma.
Simone de VriesMiriam L HaaksmaKatarzyna JóźwiakMichael SchaapveldDavid C HodgsonPieternella J LugtenburgAugustinus D G KrolEefke J PetersenDick Johan van SpronsenSameera AhmedMichael HauptmannBerthe M P AlemanFlora E van LeeuwenPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
We developed and validated prediction models for CHD and HF with good overall calibration and moderate discrimination. These models can be used to identify HL survivors who might benefit from targeted screening for CVD and early treatment for CVD risk factors.